31640277|t|GSKIP-Mediated Anchoring Increases Phosphorylation of Tau by PKA but Not by GSK3beta via cAMP/PKA/GSKIP/GSK3/Tau Axis Signaling in Cerebrospinal Fluid and iPS Cells in Alzheimer Disease.
31640277|a|Based on the protein kinase A (PKA)/GSK3beta interaction protein (GSKIP)/glycogen synthase kinase 3beta (GSK3beta) axis, we hypothesized that these might play a role in Tau phosphorylation. Here, we report that the phosphorylation of Tau Ser409 in SHSY5Y cells was increased by overexpression of GSKIP WT more than by PKA- and GSK3beta-binding defective mutants (V41/L45 and L130, respectively). We conducted in vitro assays of various kinase combinations to show that a combination of GSK3beta with PKA but not Ca2+/calmodulin-dependent protein kinase II (CaMK II) might provide a conformational shelter to harbor Tau Ser409. Cerebrospinal fluid (CSF) was evaluated to extend the clinical significance of Tau phosphorylation status in Alzheimer's disease (AD), neurological disorders (NAD), and mild cognitive impairment (MCI). We found higher levels of different PKA-Tau phosphorylation sites (Ser214, Ser262, and Ser409) in AD than in NAD, MCI, and normal groups. Moreover, we used the CRISPR/Cas9 system to produce amyloid precursor protein (APPWT/D678H) isogenic mutants. These results demonstrated an enhanced level of phosphorylation by PKA but not by the control. This study is the first to demonstrate a transient increase in phosphor-Tau caused by PKA, but not GSK3beta, in the CSF and induced pluripotent stem cells (iPSCs) of AD, implying that both GSKIP and GSK3beta function as anchoring proteins to strengthen the cAMP/PKA/Tau axis signaling during AD pathogenesis.
31640277	0	5	GSKIP	Gene	51527
31640277	54	57	Tau	Gene	4137
31640277	76	84	GSK3beta	Gene	2932
31640277	89	93	cAMP	Chemical	-
31640277	98	103	GSKIP	Gene	51527
31640277	109	112	Tau	Gene	4137
31640277	168	185	Alzheimer Disease	Disease	MESH:D000544
31640277	223	251	GSK3beta interaction protein	Gene	51527
31640277	253	258	GSKIP	Gene	51527
31640277	260	290	glycogen synthase kinase 3beta	Gene	2932
31640277	292	300	GSK3beta	Gene	2932
31640277	356	359	Tau	Gene	4137
31640277	421	424	Tau	Gene	4137
31640277	435	441	SHSY5Y	CellLine	CVCL:0019
31640277	483	488	GSKIP	Gene	51527
31640277	514	522	GSK3beta	Gene	2932
31640277	673	681	GSK3beta	Gene	2932
31640277	699	742	Ca2+/calmodulin-dependent protein kinase II	Gene	818
31640277	744	751	CaMK II	Gene	818
31640277	802	805	Tau	Gene	4137
31640277	893	896	Tau	Gene	4137
31640277	923	942	Alzheimer's disease	Disease	MESH:D000544
31640277	944	946	AD	Disease	MESH:D000544
31640277	949	971	neurological disorders	Disease	MESH:D009461
31640277	973	976	NAD	Disease	MESH:D009461
31640277	983	1008	mild cognitive impairment	Disease	MESH:D060825
31640277	1010	1013	MCI	Disease	MESH:D060825
31640277	1056	1059	Tau	Gene	4137
31640277	1114	1116	AD	Disease	MESH:D000544
31640277	1125	1128	NAD	Disease	MESH:D009461
31640277	1130	1133	MCI	Disease	MESH:D060825
31640277	1206	1231	amyloid precursor protein	Gene	351
31640277	1239	1244	D678H	ProteinMutation	tmVar:p|SUB|D|678|H;HGVS:p.D678H;VariantGroup:0;CorrespondingGene:351;RS#:63750064(Expired);CorrespondingSpecies:9606
31640277	1458	1466	GSK3beta	Gene	2932
31640277	1525	1527	AD	Disease	MESH:D000544
31640277	1548	1553	GSKIP	Gene	51527
31640277	1558	1566	GSK3beta	Gene	2932
31640277	1616	1620	cAMP	Chemical	-
31640277	1625	1628	Tau	Gene	4137
31640277	1651	1653	AD	Disease	MESH:D000544
31640277	Association	MESH:D000544	51527
31640277	Positive_Correlation	4137	51527
31640277	Association	MESH:D000544	2932
31640277	Association	MESH:D000544	4137

